scispace - formally typeset
J

J Ziegler

Researcher at International Agency for Research on Cancer

Publications -  8
Citations -  1329

J Ziegler is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Kaposi's sarcoma & Kaposi's sarcoma-associated herpesvirus. The author has an hindex of 6, co-authored 8 publications receiving 1307 citations.

Papers
More filters
Journal ArticleDOI

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

TL;DR: Antibody kinetics showed that more than half of the AIDS–KS patients who were examined IgG–seroconverted before KS development, and antibody levels did not decline after seroconversion, suggest that the rate of infection was constant and that the risk of developing KS once infected with KSHV is not highly dependent on the duration of infection.
Journal ArticleDOI

Kaposi's Sarcoma-Associated Herpesvirus and Kaposi's Sarcoma in Africa

TL;DR: As in North America and Europe, KSHV infection is strongly associated with both HIV-Seropositive and HIV-seronegative KS in Africa, however, it is likely that infection with this virus is more highly prevalent in Uganda.
Journal ArticleDOI

Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.

TL;DR: In this paper, Kaposi's sarcoma (KS) associated herpesvirus (KSHV) was detected in both endemic HIV-seronegative and HIV-Seropositive KS lesions from African patients.
Journal ArticleDOI

Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.

TL;DR: Among HIV-infected subjects, KS cases are characterized by better education and greater affluence, compared with controls, and few indices of sexual behaviour were related to risk of KS, including reported number of sexual partners.
Journal ArticleDOI

Non-Hodgkin lymphoma in Uganda: a case-control study.

TL;DR: In adults, the risk associated with HIV was much lower in Uganda than in western countries, possibly because of the poor survival of immunosuppressed HIV-positive individuals.